ANGLE PLC
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 1994-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.angleplc.com
Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System
Terminated
- Conditions
- Castration-resistant Prostate CancerProstate CancerHigh Risk Prostate CarcinomaBiochemically Recurrent Prostate Carcinoma
- Interventions
- Other: Blood collection
- First Posted Date
- 2022-06-29
- Last Posted Date
- 2023-09-05
- Lead Sponsor
- Angle plc
- Target Recruit Count
- 9
- Registration Number
- NCT05437679
- Locations
- 🇺🇸
MidLantic Urology, Pottstown, Pennsylvania, United States
Harvest of CTCs From MBC Patients Using the Parsortix™ PC1 System
Completed
- Conditions
- Healthy VolunteersBreast Cancer, Metastatic
- Interventions
- Diagnostic Test: Blood draw
- First Posted Date
- 2018-02-09
- Last Posted Date
- 2023-06-05
- Lead Sponsor
- Angle plc
- Target Recruit Count
- 421
- Registration Number
- NCT03427450
- Locations
- 🇺🇸
University of Rochester Medical Center Wilmot Cancer Institute, Rochester, New York, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
🇺🇸University of Southern California, Los Angeles, California, United States
Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.
Completed
- Conditions
- Ovarian Neoplasms
- Interventions
- Procedure: Pelvic imagingProcedure: Blood drawProcedure: laparotomy or laparoscopy
- First Posted Date
- 2016-05-30
- Last Posted Date
- 2018-11-09
- Lead Sponsor
- Angle plc
- Target Recruit Count
- 204
- Registration Number
- NCT02785731
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
🇩🇪Charité - Universitätsmedizin Berlin, Berlin, Germany
🇩🇪Vivantes-Klinikum Neukölln, Berlin, Germany
Evaluation of Multiple Protein and Molecular Biomarkers to Estimate Risk of Cancer in Gynecology Patients Presenting With a Pelvic Mass.
Completed
- Conditions
- Ovarian Neoplasms
- Interventions
- Procedure: Pelvic imagingProcedure: Blood drawProcedure: Imaging guided biopsy, surgical biopsy or surgical excision
- First Posted Date
- 2016-05-24
- Last Posted Date
- 2023-06-05
- Lead Sponsor
- Angle plc
- Target Recruit Count
- 200
- Registration Number
- NCT02781272
- Locations
- 🇺🇸
University of Rochester Medical Center Wilmot Cancer Institute, Rochester, New York, United States
© Copyright 2025. All Rights Reserved by MedPath